Formerly Corporate Officer, Takeda Executive Team, leading global portfolio commercialisation and global commercial excellence

Board Director at F2G (UK/US) and Affibody AB (Sweden)

Industrial Advisory, private equity group EQT

Earlier served in various senior operational and strategic roles at Shire, Roche, Abbott (now AbbVie), Schering Plough (now Merck & Co.) and McKinsey & Co. in Europe, US and Asia